CVRx (CVRX) Cash from Financing Activities (2020 - 2026)
CVRx's quarterly Cash from Financing Activities came in at $8.9 million in Q1 2026, down 7.62% year-on-year from $9.6 million in Q1 2025, and up 2066.34% quarter-over-quarter from $410000.0 in Q4 2025.
CVRx has reported Cash from Financing Activities for 7 years, with the latest figure at $8.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 7.62% year-over-year to $8.9 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 84.74% YoY), and the FY2025 full-year result was $10.5 million, down 81.17% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $8.9 million, up from $410000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $40.2 million in Q3 2024, with the low at $7000.0 in Q3 2022.
- Average Cash from Financing Activities over 5 years is $6.3 million, with a median of $473000.0 recorded in 2023.
- Year-over-year, Cash from Financing Activities tumbled 99.99% in 2022 and jumped 15666.67% in 2023.
- Tracing CVRX's Cash from Financing Activities over 5 years: stood at $7.1 million in 2022, then jumped by 118.91% to $15.6 million in 2023, then decreased by 11.21% to $13.8 million in 2024, then sank by 97.04% to $410000.0 in 2025, then soared by 2066.34% to $8.9 million in 2026.
- The last three Cash from Financing Activities figures came in at $8.9 million (Q1 2026), $410000.0 (Q4 2025), and $103000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 8.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.88 Mn |
| Mar 31, 2026 | 8.88 Mn |
| Dec 31, 2025 | 410,000.00 |
| Dec 31, 2025 | 410,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Jun 30, 2025 | 392,000.00 |
| Mar 31, 2025 | 9.62 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Sep 30, 2024 | 40.20 Mn |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 15.58 Mn |
| Dec 31, 2023 | 15.58 Mn |
| Sep 30, 2023 | 363,000.00 |
| Sep 30, 2023 | 363,000.00 |
| Jun 30, 2023 | 473,000.00 |
| Jun 30, 2023 | 473,000.00 |
| Mar 31, 2023 | 7.57 Mn |
| Mar 31, 2023 | 7.57 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 321,000.00 |
| Jun 30, 2022 | 321,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Mar 31, 2022 | 48,000.00 |
| Dec 31, 2021 | -21.29 Mn |
| Dec 31, 2021 | -21.29 Mn |
| Sep 30, 2021 | 133.17 Mn |
| Sep 30, 2021 | 133.17 Mn |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Sep 30, 2020 | 49.78 Mn |
| Sep 30, 2020 | 49.78 Mn |